Latest dry eye disease Stories

2014-06-12 08:29:46

-- Parion has a plan for the first clinical trial in patients with dry eye disease to initiate in July 2014 DURHAM, N.C., June 12, 2014 /PRNewswire/ -- Parion Sciences, Inc. (Parion) announced today that Parion and Santen Pharmaceutical Co., Ltd. (Santen) have entered into the "OPTION, LICENSE AND DEVELOPMENT AGREEMENT", an exclusive option agreement for the development and commercialization of P-321 for dry eye disease in certain Asian territories. On May 1, 2014 Parion announced...

2014-06-02 08:31:12

Staff expanded in preparation for initiation of pulmonary and ophthalmic clinical trials DURHAM, N.C., June 2, 2014 /PRNewswire/ -- Parion Sciences, a company dedicated to the development of novel treatments for pulmonary and ocular diseases, today announced senior leadership and organizational changes. The changes include the following: -- Paul Boucher has been promoted to President and will lead the executive management team, business development and provide overall...

2014-05-01 08:37:31

- Initiation of Phase 1/2a clinical trial in subjects with dry eye disease expected mid-2014 DURHAM, N.C., May 1, 2014 /PRNewswire/ -- Parion Sciences, a company dedicated to the development of novel treatments for ocular and pulmonary diseases, announced today that it has received acceptance from the U.S. Food and Drug Administration (FDA) of its Investigational New Drug (IND) application for P-321 Ophthalmic Solution for the treatment of dry eye disease. Preclinical data that...

2013-05-18 23:03:44

Theodore Perl, M.D. of Corneal Associates of New Jersey discussed Lipiflow for Evaporative Dry Eye Disease. Fairfield, NJ (PRWEB) May 18, 2013 Corneal Associates of New Jersey, a practice specializing in LASIK laser vision correction, cornea, cataract surgery and dry eye disease has announced that it is the one of the first practices in New Jersey to introduce a revolutionary new treatment for patients who suffer from evaporative dry eye disease. Dry eye disease is one of the most common...

2013-04-19 16:27:28

Research study online in JAMA Ophthalmology may herald new era of new highly targeted molecular treatment for common condition Dry eye disease (DED) is a common condition that causes discomfort, visual disturbance and potentially damaging ocular surface inflammation that greatly impacts a person's quality of life. An estimated nine million people in the United State alone suffer from significant DED; millions more may have milder forms or experience discomfort when exposed to low humidity...

2013-04-19 16:25:27

Conditions include dry eye disease, xerostomia (dry mouth), interstitial cystitis (bladdar inflammation), and postmenopausal vaginal atrophy Natural lubricants play an important role in health, including a well-known effect to help prevent osteoarthritis in knee and ankle joints. However, much is still unknown about their role and function in other areas of the body. Researchers for the first time have discovered that the surface of the eye produces "lubricin," the same substance that...

Word of the Day
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.